None
Quote | G1 Therapeutics Inc. (NASDAQ:GTHX)
Last: | $2.57 |
---|---|
Change Percent: | 0.0% |
Open: | $2.45 |
Close: | $2.57 |
High: | $2.61 |
Low: | $2.435 |
Volume: | 509,917 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | G1 Therapeutics Inc. (NASDAQ:GTHX)
2024-07-01 08:25:52 ET More on G1 Therapeutics G1 Therapeutics: Failure Of Breast Cancer Underscores Long-Term Uncertainty G1 Therapeutics, Inc. (GTHX) Q1 2024 Earnings Call Transcript G1 Therapeutics drops as breast cancer therapy fails in late-stage trial G...
RESEARCH TRIANGLE PARK, N.C., July 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, today announced that the Company has been added to the broad-market Russell 3000® and small-cap Russell 2000® Indexes as of...
Message Board Posts | G1 Therapeutics Inc. (NASDAQ:GTHX)
Subject | By | Source | When |
---|---|---|---|
Thinking through this more- arent most CRC tumors | sks144 | investorshub | 02/28/2023 1:44:07 AM |
Agreed! Lets see how much cash they have | stocksrising | investorshub | 02/16/2023 1:42:45 AM |
I hope they survive. Drug has real potential | sks144 | investorshub | 02/15/2023 5:59:20 PM |
Lets see how much cash they have after | stocksrising | investorshub | 02/13/2023 7:36:32 PM |
What? Oh my!!! lolzzzzzzz | SurgeGuy2.0 | investorshub | 11/01/2021 9:44:43 PM |
News, Short Squeeze, Breakout and More Instantly...
RESEARCH TRIANGLE PARK, N.C., July 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, today announced that the Company has been added to the broad-market Russell 3000® and small-cap Russell 2000® Indexes as of...
2024-06-25 08:00:05 ET Edward White from H.C. Wainwright issued a price target of $3.00 for GTHX on 2024-06-25 06:22:00. The adjusted price target was set to $3.00. At the time of the announcement, GTHX was trading at $2.22. GTHX currently trades -63.60% versus its 52 we...
A look at the top 10 most actives in the United States Agrify Corporation (AGFY) rose 164.2% to $0.6658 on volume of 125,460,313 shares NVIDIA Corporation (NVDA) fell 2.9% to $122.88 on volume of 51,163,891 shares Crown Electrokinetics Corp. (CRKN) fell 0.3% to $0.04097 on volume of 44,45...